Ophthalmology · Anniston, AL
NPI
1790856144
Since 2006
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
822 Leighton Ave
Anniston, AL, 36207
Phone (256) 237-6769
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.1M
13,175 services
Medicare patients, 2024
611
Average age 74
Drug cost, 2024
$812K
3,101 prescriptions
Company payments, 2025
$776
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Abdul A Kazi was code J2777 (injection, faricimab-svoa, 0.1 mg), 6,480 times for 22 patients. In total Abdul A Kazi billed 13,175 services in 61 codes, and Medicare paid $1.1M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-03-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2777 Injection, faricimab-svoa, 0.1 mg | Office | 6,480 | 22 | $27.48 | $178K |
| 67028 Intravitreal Injection | Office | 1,033 | 114 | $76.28 | $79K |
| 99213 Office E&M - Established | Office | 858 | 242 | $61.26 | $53K |
| 92134 Computerized Ophthalmic Imaging | Office | 757 | 138 | $27.45 | $21K |
| 99214 Office E&M - Established | Office | 728 | 437 | $75.99 | $55K |
| J0178 Injection, aflibercept, 1 mg | Office | 562 | 38 | $660.30 | $371K |
| J9035 Injection, bevacizumab, 10 mg | Office | 553 | 79 | $55.68 | $31K |
| 92250 Angiography | Office | 540 | 271 | $24.38 | $13K |
| J0177 Injection, aflibercept hd, 1 mg | Office | 286 | 17 | $263.16 | $75K |
| 92083 Vision, Hearing, and Speech Services | Office | 180 | 130 | $38.89 | $7,001 |
| 92133 Computerized Ophthalmic Imaging | Office | 154 | 111 | $20.92 | $3,221 |
| 99204 Office E&M - New | Office | 124 | 124 | $98.74 | $12K |
| 66984 Cataract Surgery | Office | 78 | 48 | $364.78 | $28K |
| 66821 Cataract Surgery | Office | 66 | 39 | $224.63 | $15K |
| 92235 Angiography | Office | 62 | 53 | $99.85 | $6,191 |
By year: 2022 $897K for 7,276 services; 2023 $973K for 10,177 services; 2024 $1.1M for 13,175 services.
Medicare prescription drug claims, 2024
In 2024, the drug Abdul A Kazi prescribed most often to Medicare patients was Restasis (Cyclosporine), with 329 prescriptions and refills. In total Abdul A Kazi wrote 3,101 Medicare prescriptions that cost $812K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Restasis Cyclosporine | 329 | 645 | 161 | $392K |
| Moxifloxacin Moxifloxacin Hcl | 277 | 279 | 145 | $9,908 |
| Erythromycin Erythromycin Base | 259 | 259 | 177 | $2,723 |
| Tobramycin-Dexamethasone Tobramycin/Dexamethasone | 208 | 224 | 168 | $9,942 |
| Ofloxacin Generic | 191 | 192 | 102 | $2,262 |
| Latanoprost Generic | 183 | 274 | 45 | $1,328 |
| Timolol Maleate Generic | 157 | 202 | 41 | $1,233 |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 117 | 163 | 34 | $12K |
| Cyclosporine Generic | 111 | 195 | 65 | $57K |
| Lumigan Bimatoprost | 92 | 130 | 35 | $32K |
| Zylet Tobramycin/Lotepred Etab | 88 | 95 | 76 | $29K |
| Simbrinza Brinzolamide/Brimonidine Tart | 85 | 114 | 25 | $18K |
| Alphagan P Brimonidine Tartrate | 80 | 107 | 30 | $21K |
| Doxycycline Hyclate Generic | 76 | 98 | 45 | $1,341 |
| Brimonidine Tartrate Generic | 73 | 107 | 35 | $8,477 |
Brand drugs: 1,446 claims; generic drugs: 1,655 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Abdul A Kazi $776 ($776 in general payments such as food, travel and fees) from 10 companies. The largest payer was Abbvie Inc. with $269.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 23 | $269 |
| Harrow Eye, LLC | 5 | $104 |
| Astellas Pharma US Inc 4503.T | 5 | $94.75 |
| Alcon Vision LLC ALC | 3 | $76.7 |
| Tarsus Pharmaceuticals, Inc. TARS | 4 | $65.28 |
| Ocular Therapeutix, Inc. OCUL | 2 | $49.12 |
| Genentech USA, Inc. ROG.SW | 2 | $33.46 |
| Dompe US, Inc. | 2 | $30.07 |
| Apellis Pharmaceuticals, Inc. APLS | 1 | $27.47 |
| Mallinckrodt Hospital Products Inc. | 1 | $26.27 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.